Investigation of pleiotropic effect of DPP-4 inhibitor, sitagliptin for type 2 diabetic patients with old myocardial infarction

Trial Profile

Investigation of pleiotropic effect of DPP-4 inhibitor, sitagliptin for type 2 diabetic patients with old myocardial infarction

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 01 Nov 2017

At a glance

  • Drugs Sitagliptin (Primary) ; Voglibose
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Acronyms MUSIC-FAIR
  • Most Recent Events

    • 30 Oct 2017 Status changed from recruiting to active, no longer recruiting.
    • 19 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top